Zoledronic Acid

Especificaciones

118072-93-8Número CAS

871-741-2Número CE

(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acidNombre IUPAC

C5H10N2O7P2Fórmula química

272.09 g/molPeso molecular

Zoledronic acid; 118072-93-8; Zoledronate; Zometa; Reclast; Aclasta; (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; Zoledronic Acid Anhydrous; Anhydrous Zoledronic Acid; CGP 42446; Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-; DTXSID0042668; ZOL 446; 70HZ18PH24; NSC-721517; [1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid; Zoledronic Acid Actavis; DTXCID8022668; (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; CHEBI:46557; Phosphonic acid, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bis-; Zoledronic Acid Teva Pharma; NSC721517; Acido zoledronico; Acide zoledronique; 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid; ZOLEDRONIC ACID TEVA GENERICS; CGP 42'446; CGP-42'446; Zerlinda; (1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl)phosphonic acid; NDC-Zoledronate; acidum zoledronicum; CGP42446; CGP42'446; RefChem:196214; CGP42446A; M05BA08; 6XC1PAD3KF; AK-156; CGP-42446; CGP-42446A; Zoladrona acid mylan; Zoledronate hydrate; Zoledronic; Zoledronic acid accord; Zoledronic acid medac; Zoledronic acid teva; (1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonic acid; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid; C5H10N2O7P2; ZOL; Orazol; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid); Zoledronic acid (INN); Reclast (TN); MFCD00867791; Zometa (TN); CHEMBL924; NCGC00159521-02; Zoledronic acid [USAN:INN:BAN]; ZOLEDRONIC ACID [INN]; Zomera; Bisphosphonate 3; Zometa (Novartis); Aclasta and Reclast; Zoledronic Acid, Anhydrous; zoledronic-acid; UNII-70HZ18PH24; BPH 91; Zoledronic Acid?; [1-HYDROXY-2-(1H-IMIDAZOL-1-YL)-ETHYLIDENE]BISPHOSPHONIC ACID; Zoledronic Acid (Standard); Zoledronic acid, Zoledronate; BIDD:PXR0134; SCHEMBL19054; ZOLEDRONIC ACID [MI]; BIDD:GT0292; Zoledronic Acid (Zoledronate); GTPL3177; JMC515594 Compound 55; orb1300511; BDBM12578; ZOLEDRONIC ACID [WHO-DD]; (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid; GLXC-08088; HMS2089O09; ALBB-038596; PXB69479; Tox21_111739; EBC-26389; HB0674; HY-13777R; s1314; STL452893; AKOS005145739; AB07564; AC-1092; CS-1829; DB00399; HS-0091; NSC 721517; NCGC00159521-03; NCGC00159521-04; NCGC00159521-05; NCGC00159521-09; NCGC00159521-11; NCGC00159521-18; HY-13777; CAS-118072-93-8; NS00006387; T6739; Z0031; D08689; EN300-117269; H11422; S00092; AB01273947-01; AB01273947-02; AB01273947-03; AB01273947_04; F812863; Q218507; SR-05000001436; SR-05000001436-1; BRD-K84253429-001-03-6; BRD-K84253429-001-04-4; 1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic Acid; Z1501485360; (1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonicacid; 1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid; (1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonic acid; (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; 1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]-bisphosphonic Acid Hydrate; 2-(Imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic Acid Hydrate;Sinónimos